Login / Signup

Cutaneous B-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.

Alexandra C HristovTrilokraj TejasviRyan A Wilcox
Published in: American journal of hematology (2020)
Both PCFCL and PCMZL patients with solitary or relatively few skin lesions may be effectively managed with local radiation therapy. While single-agent rituximab may be employed for patients with more widespread skin involvement, multi-agent chemotherapy is rarely appropriate. In contrast, management of patients with PCDLBCL, LT is comparable to the management of patients with systemic DLBCL.
Keyphrases
  • radiation therapy
  • diffuse large b cell lymphoma
  • magnetic resonance
  • soft tissue
  • magnetic resonance imaging
  • computed tomography
  • contrast enhanced